Form D · Other Health Care
Nuvo Group Ltd.
Tel Aviv, L3 · CIK 0001861520
Offering snapshot reported Jun 24, 2021 · SEC filing
- Reported sold
- $25M Offering amount: $25M
- Investors reported
- 47 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- May 3, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 24, 2021 | Initial | $25,000,000 | No comparison | 47 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-404024
Source: Form D, filed Jun 24, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Gilcher | Director |
| Deborah Henretta | Director |
| Stephen Klasko | Director |
| Laurence Klein | Director |
| Gerald Ostrov | Director |
| Oren Oz | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
Yigal Alon 94, Alon Tower 1
Tel Aviv, L3, 6789155
Tel Aviv, L3, 6789155